Skip to content

← All stories

Markets

Evommune stock maintains Buy rating despite trial setback

1 source ·1 article ·1h ago

Covered by 1 outlet

All coverage · 1 article

Investing.com UK ·1h ago

Evommune stock maintains Buy rating despite trial setback